Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 92%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
46,410
Total Claims
$5.0M
Drug Cost
1,019
Beneficiaries
$4,872
Cost/Patient
Risk Score Breakdown 30/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-40%
Opioid rate vs peers
1.3% vs 2.2% avg
+245%
Cost per patient vs peers
$4,872 vs $1,411 avg
+64%
Brand preference vs peers
17.4% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.3%
Opioid Rate
624
Opioid Claims
$9,996
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 7,973 claims · $4.1M
Generic: 37,780 claims · $851K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 750 | $378K |
| Empagliflozin | 368 | $265K |
| Valbenazine Tosylate | 23 | $181K |
| Dapagliflozin Propanediol | 244 | $160K |
| Dulaglutide | 221 | $157K |
| Semaglutide | 149 | $153K |
| Insulin Glargine,hum.Rec.Anlog | 238 | $136K |
| Etanercept | 14 | $111K |
| Fluticasone/Umeclidin/Vilanter | 144 | $108K |
| Rivaroxaban | 177 | $101K |
| Paliperidone Palmitate | 29 | $90K |
| Linaclotide | 144 | $89K |
| Pimavanserin Tartrate | 27 | $87K |
| Rifaximin | 40 | $80K |
| Semaglutide | 77 | $80K |
Prescribing Profile
Patient Profile
69
Avg Age
57%
Female
1.85
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About